Astrana Health (NASDAQ:ASTH – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $1.28 to $1.52 for the period, compared to the consensus EPS estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.
Wall Street Analyst Weigh In
ASTH has been the topic of several analyst reports. Jefferies Financial Group assumed coverage on Astrana Health in a research report on Monday, February 26th. They set a buy rating and a $50.00 target price on the stock. Truist Financial boosted their price objective on Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a research note on Friday, March 1st.
Get Our Latest Stock Analysis on Astrana Health
Astrana Health Trading Down 1.0 %
Astrana Health (NASDAQ:ASTH – Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.09. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The firm had revenue of $353.00 million during the quarter, compared to analysts’ expectations of $341.17 million. During the same quarter last year, the business posted $0.02 earnings per share. The firm’s revenue was up 20.0% on a year-over-year basis. As a group, equities research analysts forecast that Astrana Health will post 1.65 earnings per share for the current year.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
See Also
- Five stocks we like better than Astrana Health
- Transportation Stocks Investing
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is the Nikkei 225 index?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Invest in Blue Chip Stocks
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.